Kite Pharma

Kite Pharma is an American biotechnology company that develops cancer immunotherapy products, with a primary focus on genetically engineered autologous CAR T cell therapy, a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.

Kite Pharma, Inc.
Company typeSubsidiary
IndustryBiopharmaceutical
Founded2009 (2009)
FounderArie Belldegrun and Joshua Kazam
FateAcquired by Gilead Sciences
Headquarters
Santa Monica
,
California
Key people
  • Christi Shaw (CEO)
  • Mert Aktar (Head of Corporate Development)
  • Warner Biddle (Global Head of Commercial)
ProductsCancer immunotherapy
Number of employees
2,000
ParentGilead Sciences
Websitewww.kitepharma.com
Footnotes / references
Key People, Founder
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.